CN112047924B — 一种沃克洛多的制备方法
Assigned to Shandong Huihai Pharmaceutical& Chemical Co ltd · Expires 2023-04-18 · 3y expired
What this patent protects
本发明涉及一种沃克洛多的制备方法,以6‑溴水杨醛为原料,与3‑(氯甲基)‑2‑(1‑异丙基‑1H‑吡唑‑5‑基)吡啶盐酸盐反应得到2‑溴‑6‑((2‑(1‑异丙基‑1H‑吡唑‑5‑基)吡啶‑3‑基)甲氧基)苯甲醛,再在RockPhos Pd G3的催化下进行温和的溴代芳香烃的酚羟基化反应,得到沃克洛多。工艺步骤短,反应条件温和,操作简便,避免了易燃易爆试剂的使用和反应条件限制。
USPTO Abstract
本发明涉及一种沃克洛多的制备方法,以6‑溴水杨醛为原料,与3‑(氯甲基)‑2‑(1‑异丙基‑1H‑吡唑‑5‑基)吡啶盐酸盐反应得到2‑溴‑6‑((2‑(1‑异丙基‑1H‑吡唑‑5‑基)吡啶‑3‑基)甲氧基)苯甲醛,再在RockPhos Pd G3的催化下进行温和的溴代芳香烃的酚羟基化反应,得到沃克洛多。工艺步骤短,反应条件温和,操作简便,避免了易燃易爆试剂的使用和反应条件限制。
Drugs covered by this patent
- Oxbryta (voxelotor) · Global Blood Theraps
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.